Patterson Companies

Patterson Cos., Inc. provides products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Patterson Companies Inc. reports strong Q4 performance and outlines growth strategies for fiscal 2024

Patterson Companies Inc. delivered strong financial results for Q4 2023, with a focus on sustained margin improvement and strategic growth opportunities. Despite challenges in free cash flow and market moderation, the company is well-positioned to leverage its strengths and capitalize on opportunities in the dental and animal health segments.

Patterson Companies Inc. reports strong Q2 earnings and focuses on private label growth

Patterson Companies Inc. delivered strong financial performance in Q2 2023, driven by growth in both the Dental and Animal Health segments. The company reaffirmed fiscal '24 earnings guidance and highlighted the potential of private label products. Despite tax and interest rate challenges, the company remains optimistic and focused on strategic initiatives to drive future growth.

Patterson Companies excels in Q3, eyes international growth opportunities

Patterson Companies reported a strong Q3 performance with internal sales growth and margin improvements. Challenges in the Dental segment were offset by growth in the Animal Health segment. The company highlighted strategic acquisitions, leadership appointments, and operational enhancements as key drivers of success. Opportunities lie in stable patient traffic, international investments, and exploring M&A in dental specialties for future growth.

Patterson Companies reports strong Q4 performance and strategic growth focus

Patterson Companies had a robust Q4 performance, showcasing growth in sales and margins. Despite challenges in the companion animal market, the company is strategically positioned for growth through software investments and service enhancements. Opportunities lie in sustained sales growth, margin expansion, and strategic market positioning.

Patterson Companies reports strong Q1 results amidst strategic focus

Patterson Companies delivered strong Q1 '24 results with growth in sales and adjusted EPS. The company is strategically focusing on private label products and efficiency improvements. While facing challenges like deflationary impacts and inflationary pressures, Patterson sees opportunities in Dental equipment growth and continued investments for long-term profitability.

Patterson Companies reports strong Q2 performance amidst market challenges

Patterson Companies delivered a solid performance in Q2 2024, driven by growth in Dental and Animal Health segments.
Despite challenges like macroeconomic headwinds and pricing pressures, the company remains focused on efficiency and driving demand.
Opportunities exist for Patterson to capitalize on market trends, optimize operations, and explore new growth avenues.
Investors should monitor how Patterson navigates challenges and leverages strengths to achieve its revised fiscal guidance.

Patterson Companies reports solid Q3 performance amidst market challenges

Patterson Companies delivered a solid performance in Q3 2024, with a focus on revenue growth, margin expansion, and strategic investments in distribution and software offerings.
While facing challenges in certain segments, the company remains committed to operational efficiency, margin integrity, and long-term growth initiatives.
Opportunities lie in sustaining sales growth, expanding market presence, and capitalizing on improvements in equipment demand and margin enhancement.
Overall, Patterson's strategic focus on growth, efficiency, and innovation positions the company for long-term success in the market.

Patterson Companies Reports Stable Q4, Eyes Strategic Growth

Patterson Companies concluded fiscal 2024 with stable financial performance, facing some headwinds in the Dental segment but offset by gains in Animal Health and strategic tech investments. The company is poised for modest growth in 2025, backed by ongoing investments in high-margin areas and a strong focus on innovation and market expansion.

Patterson Companies addresses challenges in Q1 2025 earnings call

Patterson Companies faced challenges in Q1 2025, with declines in both the Dental and Animal Health segments.
Despite these challenges, management is taking actions to improve performance and profitability for the rest of fiscal 2025.
The company's focus on cost management and operational efficiency is a strength in navigating the current environment.
Opportunities exist in strengthening the companion animal business, improving internal sales, and enhancing cybersecurity measures.

Patterson Companies explores strategic options amidst mixed Q2 performance

Patterson Companies navigated Q2 with a focus on cost management, strategic investments, and long-term growth. The company faces challenges in the Dental segment but sees opportunities in maximizing shareholder value and leveraging stable patient traffic.
Despite headwinds in equipment sales, Patterson Companies remains committed to efficiency optimization and margin enhancement, positioning itself for sustained growth and value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Patterson Cos., Inc. engages in the provision of products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

Patterson enters into a definitive agreement to be acquired by Patient Square Capital at a valuation of approximately $4.1 billion.

PDCO Stock Gains on the News of Acquisition Deal With Patient Square

On Wednesday, Patient Square Capital, a healthcare investment firm, agreed to acquire Patterson Companies, Inc.  PDCO, a dental and animal health product distributor, for approximately $4.1 billion.

What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players?

Patterson Companies' shares surged 35.9% after announcing an all-cash buyout by Patient Square Capital, valuing the company at $4.1 billion. Despite the buyout, some investors feel the deal leaves money on the table, but the stock's appreciation is a net positive. The go-shop period allows management to seek better offers, suggesting potential for a higher bid, making it wise to hold shares.

Patterson Companies Surges As The Market Prices In More Upside (Rating Downgrade)

NEW YORK , Dec. 11, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Patterson Companies, Inc. (NASDAQ: PDCO ), relating to the proposed merger with Patient Square Capital.

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Patterson Companies, Inc. - PDCO

On Wednesday, Patient Square Capital, a healthcare investment firm, agreed to acquire Patterson Companies, Inc.  PDCO, a dental and animal health product distributor, for approximately $4.1 billion.

Dental Product Supplier Patterson Companies Goes Private In $4.1 Billion Deal

Patterson Companies stock launched Wednesday after the dental outfit said it agreed to a $4.1 billion takeover deal from Patient Square. The post Patterson Launches On $4.1 Billion Takeover.

Patterson Launches On $4.1 Billion Takeover. Can It Reinvigorate The Beleaguered Dental Space?

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Patterson Companies, Inc. (NASDAQ: PDCO) to Patient Square Capital for $31.35 in cash per share is fair to Patterson shareholders. Halper Sadeh encourages Patterson shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns wheth.

PDCO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Patterson Companies, Inc. Is Fair to Shareholders

Shareholders will receive $31.35 in cash per share under terms of the deal.

Patterson Cos. to Be Acquired by Patient Square Capital for $4.1 Billion

MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Patterson (Nasdaq: PDCO) for possible breaches of fiduciary duty and other violations of law in its transaction with Patient Square. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, Patterson shareholders will receive $31.35 in cash per share. Patterson insiders will receive substanti.

Shareholder Alert: Ademi LLP Investigates Whether Patterson Companies, Inc. Is Obtaining a Fair Price for Its Public Shareholders

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO), a leading dental and animal health distributor, today announced that it has entered into a definitive agreement to be acquired by Patient Square Capital (Patient Square), a dedicated health care investment firm. Under the terms of the agreement, Patterson shareholders will receive $31.35 in cash per share, representing an approximately 49% premium to Patterson's 30 calendar day volume-weighted average price (VWAP) endin.

Patterson Companies Announces Definitive Agreement to Be Acquired by Patient Square Capital for $31.35 Per Share in Cash

Patterson Approved Vendor status will pave the way for customers to securely use new payments capabilities. VALHALLA, N.Y.

Rectangle Health Collaborates with Patterson Dental to Enhance Payment Solutions for Healthcare Providers

Patterson Companies' overall topline in the second quarter of fiscal 2025 benefits from strength in its Animal Health segment.

PDCO Stock Gains Despite Q2 Earnings Miss and Lower Margins

Patterson Companies, Inc. (NASDAQ:PDCO ) Q2 2025 Earnings Conference Call December 5, 2024 8:30 AM ET Company Participants John Wright - Vice President, Investor Relations Don Zurbay - President and Chief Executive Officer Kevin Barry - Chief Financial Officer Conference Call Participants Michael Cherny - Leerink Partners Jeffrey Johnson - Baird Kevin Caliendo - UBS Jonathan Block - Stifel Erin Wright - Morgan Stanley Jason Bednar - Piper Sandler Sameer Patel - Evercore ISI Allen Lutz - Bank of America Steven Valiquette - Mizuho Securities Brandon Vazquez - William Blair Operator Thank you for standing by and welcome to the Patterson Companies' Second Quarter Fiscal 2025 Earnings Conference Call. All lines have been placed on mute to prevent any background noise.

Patterson Companies, Inc. (PDCO) Q2 2025 Earnings Call Transcript

Dental supply maker Patterson Companies Inc PDCO announced Thursday that it is exploring strategic options, including a sale or merger, to boost shareholder value.

Dental Supplier Patterson Companies Is Up For Sale After Posting Mixed Q2 Earnings

While the top- and bottom-line numbers for Patterson Cos. (PDCO) give a sense of how the business performed in the quarter ended October 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Compared to Estimates, Patterson Cos. (PDCO) Q2 Earnings: A Look at Key Metrics

Patterson Cos. (PDCO) came out with quarterly earnings of $0.47 per share, missing the Zacks Consensus Estimate of $0.49 per share.

Patterson Cos. (PDCO) Lags Q2 Earnings Estimates

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) today reported operating results for its fiscal 2025 second quarter ended October 26, 2024. "Our second quarter results were mixed, given the challenging end market environment,” said Don Zurbay, President and CEO of Patterson Companies. “To support sustainable, long-term growth, we took dedicated cost management actions to optimize our operations, made targeted investments in complementary businesses and invested in enh.

Patterson Companies Reports Fiscal 2025 Second Quarter Operating Results

AbbVie

Bristol-Myers

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Patterson Cos. (PDCO), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended October 2024.

Ahead of Patterson Cos. (PDCO) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics

PDCO's fiscal second-quarter results are likely to reveal a decline in both the Dental and Animal Health segments, reflecting challenges like moderating traffic to clinics.

Macro Challenges to Hurt Patterson Companies' Q2 Earnings?

Investors remain optimistic about Patterson Companies on the back of its broad product line.

Here's Why You Should Retain PDCO Stock in Your Portfolio for Now

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies (Nasdaq: PDCO) today announced that it will hold its fiscal 2025 second-quarter conference call on Thursday, December 5, 2024, at 7:30 a.m. CT (8:30 a.m. ET). The company's earnings release will be issued that morning before the market opens. To access the live webcast, go to the investor relations section of the company's website, www.PattersonCompanies.com. An audio replay of the fiscal 2025 second-quarter conference call will also be avai.

Patterson Companies Fiscal 2025 Second Quarter Conference Call Scheduled for Thursday, December 5, 2024

CVS Health

Pfizer

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields

PDCO's latest agreement with PDS Health to extend their deal is likely to streamline operations, optimize efficiency and maximize profitability.

Patterson Companies Stock Up Following Latest Partnership Extension

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Dental Supply, Inc., a subsidiary of Patterson Companies, Inc. (Nasdaq: PDCO), today announced an agreement in principle between Patterson and PDS Health, a leading dental and medical support organization formerly known as Pacific Dental Services, to extend their strategic relationship through the end of 2027. The extension allows Patterson to continue as the premier distributor for all merchandise, services, technology and core equipment across PDS H.

News for Patterson Companies Stock (PDCO)